Digital Contact Tracing for Pandemic Response: Ethics and Governance Guidance

Portada
Jeffrey P. Kahn, Johns Hopkins Project on Ethics and Governance of Digital Contact Tracing Technologies
JHU Press, 2020 M05 29 - 160 páginas

As nations race to hone contact-tracing efforts, the world's experts consider strategies for maximum transparency and impact.

As public health professionals around the world work tirelessly to respond to the COVID-19 pandemic, it is clear that traditional methods of contact tracing need to be augmented in order to help address a public health crisis of unprecedented scope. Innovators worldwide are racing to develop and implement novel public-facing technology solutions, including digital contact tracing technology. These technological products may aid public health surveillance and containment strategies for this pandemic and become part of the larger toolbox for future infectious outbreak prevention and control.

As technology evolves in an effort to meet our current moment, Johns Hopkins Project on Ethics and Governance of Digital Contact Tracing Technologies—a rapid research and expert consensus group effort led by Dr. Jeffrey P. Kahn of the Johns Hopkins Berman Institute of Bioethics in collaboration with the university's Center for Health Security—carried out an in-depth analysis of the technology and the issues it raises. Drawing on this analysis, they produced a report that includes detailed recommendations for technology companies, policymakers, institutions, employers, and the public. The project brings together perspectives from bioethics, health security, public health, technology development, engineering, public policy, and law to wrestle with the complex interactions of the many facets of the technology and its applications.

This team of experts from Johns Hopkins University and other world-renowned institutions has crafted clear and detailed guidelines to help manage the creation, implementation, and application of digital contact tracing. Digital Contact Tracing for Pandemic Response is the essential resource for this fast-moving crisis.

Contributors: Joseph Ali, JD; Anne Barnhill, PhD; Anita Cicero, JD; Katelyn Esmonde, PhD; Amelia Hood, MA; Brian Hutler, Phd, JD; Jeffrey P. Kahn, PhD, MPH; Alan Regenberg, MBE; Crystal Watson, DrPH, MPH; Matthew Watson; Robert Califf, MD, MACC; Ruth Faden, PhD, MPH; Divya Hosangadi, MSPH; Nancy Kass, ScD; Alain Labrique, PhD, MHS, MS; Deven McGraw, JD, MPH, LLM; Michelle Mello, JD, PhD; Michael Parker, BEd (Hons), MA, PhD; Stephen Ruckman, JD, MSc, MAR; Lainie Rutkow, JD, MPH, PhD; Josh Sharfstein, MD; Jeremy Sugarman, MD, MPH, MA; Eric Toner, MD; Mar Trotochaud, MSPH; Effy Vayena, PhD; Tal Zarsky, JSD, LLM, LLB

 

Páginas seleccionadas

Contenido

Summary
1
Introduction
23
1 Public Health Perspective
29
2 Digital Technology and Contact Tracing
35
3 Ethics of Designing and Using DCTT
43
4 Legal Considerations
75
5 Recommendations
97
Resources
103
Works Cited
127
Derechos de autor

Otras ediciones - Ver todas

Términos y frases comunes

Acerca del autor (2020)

Johns Hopkins Project on Ethics and Governance of Digital Contact Tracing Technologies is a rapid research and expert consensus group effort led by the Berman Institute of Bioethics in collaboration with the Center for Health Security at Johns Hopkins University. It draws on experts from both inside and outside Johns Hopkins in bioethics, health security, public health, technology development, engineering, public policy, and law. Jeffrey P. Kahn, PhD, MPH, is the Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics. He is also the Levi Professor of Bioethics and Public Policy there, as well as a professor in the Department of Health Policy and Management at the Johns Hopkins University Bloomberg School of Public Health. His research interests include the ethics of research, ethics and public health, and ethics and emerging biomedical technologies. He speaks widely both in the United States and abroad, and has published four books and over 125 articles in the academic literature. He is an elected member of the National Academy of Medicine and a fellow of the Hastings Center, and he has chaired or served on committees and panels for the National Institutes of Health, the Centers for Disease Control and Prevention, and the National Academy of Medicine (NAM), where he is currently the chair of the Board on Health Sciences Policy and a member of the NAM Council. His education includes a BA in microbiology (University of California–Los Angeles, 1983), an MPH (Johns Hopkins University, 1988), and a PhD in philosophy (Georgetown University, 1989).

Información bibliográfica